Novo Nordisk
NVO
#15
Rank
A$896.71 B
Marketcap
$202.30
Share price
2.14%
Change (1 day)
39.95%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Total debt

Total debt on the balance sheet as of June 2024 : A$12.31 B

According to Novo Nordisk's latest financial reports the company's total debt is A$12.31 B. A companyโ€™s total debt is the sum of all current and non-current debts.

Novo Nordisk - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2023-12-31A$5.87 B7.59%
2022-12-31A$5.45 B-2.2%
2021-12-31A$5.57 B151.14%
2020-12-31A$2.22 B132.34%
2019-12-31A$0.95 B753.99%
2018-12-31A$0.11 B-67.99%
2017-12-31A$0.34 B677.66%
2016-12-31A$44.98 M-79.16%
2015-12-31A$0.21 B50.53%
2014-12-31A$0.14 B221.34%
2013-12-31A$44.62 M-47.81%
2012-12-31A$85.51 M-41%
2011-12-31A$0.14 B-63.03%
2010-12-31A$0.39 B31.13%
2009-12-31A$0.29 B-52.64%
2008-12-31A$0.63 B106.4%
2007-12-31A$0.30 B-10.22%
2006-12-31A$0.34 B-41.52%
2005-12-31A$0.58 B45.08%
2004-12-31A$0.40 B1.85%
2003-12-31A$0.39 B7.81%
2002-12-31A$0.36 B-25.53%
2001-12-31A$0.49 B4.76%
2000-12-31A$0.46 B3.52%
1999-12-31A$0.45 B-32.31%
1998-12-31A$0.66 B-5.44%
1997-12-31A$0.70 B64.68%
1996-12-31A$0.42 B

Total debt for similar companies or competitors

Company Total debt differencediff. Country
A$103.00 B 736.11%๐Ÿ‡บ๐Ÿ‡ธ USA
A$43.33 B 251.75%๐Ÿ‡บ๐Ÿ‡ธ USA
A$80.99 B 557.48%๐Ÿ‡บ๐Ÿ‡ธ USA
A$38.18 B 209.97%๐Ÿ‡ซ๐Ÿ‡ท France